USRE35865E - Preparation of glutaric acid derivatives - Google Patents

Preparation of glutaric acid derivatives Download PDF

Info

Publication number
USRE35865E
USRE35865E US08/856,612 US85661297A USRE35865E US RE35865 E USRE35865 E US RE35865E US 85661297 A US85661297 A US 85661297A US RE35865 E USRE35865 E US RE35865E
Authority
US
United States
Prior art keywords
alkoxy
formula
compound
tert
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/856,612
Inventor
Stephen Challenger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10654523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=USRE35865(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Corp SRL filed Critical Pfizer Corp SRL
Priority to US08/856,612 priority Critical patent/USRE35865E/en
Application granted granted Critical
Publication of USRE35865E publication Critical patent/USRE35865E/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/313—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Definitions

  • This invention relates to a process for the preparation of glutaric acid derivatives.
  • the invention relates to a process for the preparation of 1- 2-(alkoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid derivatives, the use of which has previously been disclosed in EP-A-0274334 as intermediates for the preparation of certain substituted glutaramide diuretic agents having utility in the treatment of hypertension, heart failure, renal insufficiency and in other disorders.
  • EP-A-0274234 describes two methods for the preparation of 1- 2-(alkoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid derivatives by which the dianion derived from cyclopentanecarboxylic acid by treatment with a strong base, e.g. lithium diisopropylamide, is treated with either (i) an acrylate derivative, or (ii) an ester of 3-bromopropanoic acid followed by optional further alkylation as required, to provide the desired products.
  • a strong base e.g. lithium diisopropylamide
  • 1- 2-(alkoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid derivatives may be unexpectedly prepared by the oxidative rearrangement of 2-acyl- or 2-alkoxycarbonyl-cyclohexanone derivatives, offering further commercially important improvements over the existing processes such as ease and lower cost of operation.
  • the present invention provides a process for preparing a compound of the formula: ##STR3## or a base salt thereof, wherein R 2 is hydrogen or C 1 -C 6 alkyl optionally substituted by up to 3 substituents each independently selected from C 1 -C 6 alkoxy and C 1 -C 6 alkoxy (C 1 -C 6 alkoxy)-; and R 3 is C 1 -C 6 alkyl or benzyl, said benzyl group being optionally ring-substituted by up to 2 nitro or C 1 -C 4 alkoxy substituents, comprising reacting a compound of the formula: ##STR4## wherein R 1 is C 1 -C 4 alkyl, phenyl, benzyl or C 1 -C 4 alkoxy; and R 2 and R 3 are as previously defined for a compound of the formula (I), with hydrogen peroxide or a source of peroxide ions.
  • the process can followed by conversion of the compound of the formula (I) to
  • R 1 is C 1 -C 4 alkyl, phenyl or C 1 -C 4 alkoxy. More preferably, R 1 is methyl, phenyl or ethoxy. Most preferably, R 1 is methyl or ethoxy.
  • R 2 is hydrogen or C 1 -C 6 alkyl optionally substituted by one C 1 -C 6 alkoxy or C 1 -C 6 alkoxy (C 1 -C 6 alkoxy)- substituent.
  • R 2 is hydrogen, 2-methoxyethoxymethyl, 2-methoxyethyl or methoxymethyl.
  • R 2 is hydrogen or 2-methoxyethoxymethyl.
  • R 3 is C 1 -C 6 alkyl or benzyl, said benzyl group being optionally ring-substituted by one nitro or C 1 -C 4 alkoxy substituent.
  • R 3 is ethyl, tert-butyl, benzyl, 4-nitrobenzyl or 4-methoxybenzyl.
  • R 3 is tert-butyl.
  • base salts of the compounds of the formula (I) include alkali metal, alkaline earth metal, ammonium and mono-, di- or tri(C 1 -C 4 alkyl)ammonium salts.
  • the base salt of a compound of the formula (I) is the isopropylammonium salt.
  • the present invention also relates to novel compounds of the formula (II) which are useful as intermediates in the preparation of certain substituted glutaride diuretic agents having utility in the treatment of hypertension, heart failure, renal insufficiency, and in other disorders.
  • the source of peroxide ions includes reagents such as hydrogen peroxide, peroxy acids (e.g. peroxy(C 1 -C 4 )alkanoic acids), sodium perborate or a hydrate thereof, and sodium percarbonate, which are used in the presence of water.
  • peroxy acids e.g. peroxy(C 1 -C 4 )alkanoic acids
  • sodium perborate or a hydrate thereof e.g. peroxy(C 1 -C 4 )alkanoic acids
  • sodium perborate or a hydrate thereof e.g. peroxy(C 1 -C 4 )alkanoic acids
  • sodium perborate or a hydrate thereof e.g. sodium percarbonate
  • sodium percarbonate sodium percarbonate
  • the reaction is preferably carried out using hydrogen peroxide in the presence of water.
  • the reaction is preferably carried out in a suitable solvent in the presence of acid or base. Although the reaction does proceed slowly under neutral conditions, it has been found that acidic or basic reaction conditions accelerate the rate.
  • Suitable solvents for the reaction include C 1 -C 6 alkanols and toluene.
  • the solvent is methanol, tert-butanol or toluene.
  • the solvent is tert-butanol.
  • preferred acids include mineral acids and C 1 -C 4 alkanoic acids.
  • the acid is sulphuric acid or acetic acid.
  • the reaction may also be carried out using a C 1 -C 4 alkanoic acid as the solvent in the absence of an additional acid.
  • Acetic acid is preferred.
  • preferred bases include sodium or potassium hydroxide, carbonate or bicarbonate.
  • the base is sodium hydroxide or sodium or potassium bicarbonate.
  • Sodium percarbonate is a basic reagent per se and is typically not used in the presence of acid or a further base.
  • reaction conditions and, in particular, the solvent and the nature and/or concentration of the acid or base used in the process provided by the present invention are chosen such that the reaction proceeds safely and at a favorable rate, without hydrolysis or transesterification of the ester functionality in the starting material (II) or product (I) occurring.
  • a preferred embodiment of the present invention provides a process for preparing a compound of the formula (I), or a base salt thereof, comprising reaction of a compound of the formula (II) with
  • R 1 , R 2 and R 3 are as previously defined for compounds of the formulae (I) and (II).
  • a most preferred embodiment of the present invention provides a process for preparing a compound of the formula (I), or a base salt thereof, comprising reaction of a compound of the formula (II) with
  • Sodium perborate is commercially available in several different hydrate forms, although the tetrahydrate (e.g. available from the Aldrich Chemical Company Ltd.) is preferred for the purpose of the present invention.
  • Sodium perborate tetrahydrate may be formulated as either NaBO 3 .4H 2 O or NaBO 2 .H 2 O 2 .3H 2 O and provides a source of peroxide ions in aqueous solution:
  • Sodium percarbonate is a commercially available (e.g. from Fluka Chemicals Ltd.) bleaching agent and provides a source of peroxide ions in the presence of water.
  • the molecular formula is generally represented as Na 2 CO 3 .3/2 H 2 O 2 (see Chem. Lett., 1986, 665-6).
  • Alkyl and alkoxy groups containing 3 or more carbon atoms and C 4 -alkanoic acids may be straight or branched chain.
  • a stirred solution of a compound of the formula (II) in a suitable organic solvent e.g. t-butanol or toluene
  • a suitable organic solvent e.g. t-butanol or toluene
  • the reaction is further stirred at room temperature for up to 24 hours although longer reaction times may be necessary.
  • the product of the formula (I) is isolated and purified using conventional techniques.
  • a stirred solution of compound of the formula (II) in a suitable organic solvent e.g. C 1 -C 4 alkanol such as tert-butanol or methanol
  • a suitable base e.g. sodium or potassium hydroxide or bicarbonate
  • an aqueous (typically about 30 weight %) solution of hydrogen peroxide maintaining the reaction temperature at from 0° C. to 50° C. throughout the additions.
  • the reaction is further stirred at from room temperature to 50° C. for up to 24 hours, or longer if necessary.
  • the product of the formula (I) is isolated and purified by conventional techniques.
  • a stirred solution of a compound of the formula (II) in a suitable organic solvent e.g. a C 1 -C 4 alkanol such as tert-butanol, is treated with sodium percarbonate at about room temperature.
  • a suitable organic solvent e.g. a C 1 -C 4 alkanol such as tert-butanol
  • the reaction is stirred at from room temperature to 60° C. for about 24 hours.
  • the product of the formula (I) is isolated and purified by conventional techniques.
  • reaction time will vary in each individual case dependent on several factors, such as the nature of the substituents and the reaction temperature employed.
  • the course of the reaction may be monitored using conventional methods, e.g. thin-layer chromatography.
  • the starting materials of the formula (II) may be prepared by a Michael addition reaction as illustrated in Scheme 1, using comparable reaction conditions to those described by Kryshtal et al, Synthesis, 1979!, 107. ##STR5## wherein R 1 , R 2 and R 3 are as previously defined for a compound of the formula (I).
  • an acrylate derivative of the formula (IV) is added to a stirred mixture of a compound of the formula (III), potassium carbonate and a catalytic amount of benzyltriethylammonium chloride in toluene at about room temperature, and the reaction further stirred at from room temperature to 50° C., preferably at about 40° C., for up to 24 hours.
  • the product of the formula (II) is isolated and purified using conventional techniques.
  • the reaction may also be performed in the absence of benzyltriethylammonium chloride by reacting a compound of the formula (III) with an acrylate derivative of the formula (IV) in the presence of a suitable base, e.g. potassium carbonate or potassium tert-botoxide, in a suitable organic solvent, e.g. a C 1 -C 4 tert-butanol) or acetonitrile, at about room temperature.
  • a suitable base e.g. potassium carbonate or potassium tert-botoxide
  • a suitable organic solvent e.g. a C 1 -C 4 tert-butanol
  • R 2 is other than hydrogen in this reaction and potassium tert-butoxide is used as the base, it is preferably added to the reaction mixture at about -10° C. and this is followed by a period of stirring of the reaction at from 0° C. to room temperature.
  • the product of the formula (II) is isolated and purified by conventional techniques.
  • the compounds of the formula (III) and the acrylate derivatives of the formula (IV) arc either known compounds which may also be commercially available, or are prepared by conventional methods in accordance with literature precedents.
  • a base salt of a compound of the formula (I) may be prepared by mixing together solutions containing approximately equimolar amounts of a compound of the formula (I) and a suitable base. The base salt is recovered by filtration or by filtration or by evaporation of the solvent.
  • the mixture was partitioned between toluene (25 ml) and 5% aqueous sodium sulphite solution and the layers separated.
  • the toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4 ⁇ 25 ml).
  • the combined aqueous extracts were washed with toluene (25 ml), acidified to pH 2-3 with 5.0N aqueous hydrochloric acid solution and extracted with toluene (3 ⁇ 25 ml).
  • the combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give an oil, (1.11 g, 61%).
  • the crude product was crystallized from pentane (7.5 ml/g) to give the title compound as a colorless solid.
  • Rf. 0.28 sica, hexane/ethyl acetate 2:1).
  • the dichloromethane layer was washed with water (10 ml), the combined aqueous extracts acidified to pH 2 with 5.0M aqueous hydrochloric acid solution and extracted with n-hexane (2 ⁇ 20 ml).
  • the combined n-hexane extracts were washed with water (5 ml), concentrated under reduced pressure and azeotropically dried with ethyl acetate to give the title acid, (3.99 g, 96% by GC normalization).
  • Rf. 0.44 sica, ethyl acetate, 1% acetic acid).
  • the crude product (3.4 g, 0.01 mol) was dissolved in 34 ml of n-hexane and isopropylamine (0.61 g, 0.01 mol) added at room temperature.
  • the precipitated salt was cooled to 0° C., granulated for 2 hours and collected to give the title compound (3.57 g, 72.1% overall yield; HPLC main band assay 98.7%), m.p. 84°-87° C.
  • the toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4 ⁇ 25 ml).
  • the combined aqueous extracts were washed with toluene (25 ml), acidified to pH 2-3 with 5.ON aqueous hydrochloric acid solution and extracted with toluene (3 ⁇ 25 ml).
  • the combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give an oil which solidified on standing, (0.96 g, 61.9%).
  • the toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4 ⁇ 25 ml).
  • the combined aqueous extracts were washed with toluene (25 ml), acidified to pH 2-3 with 5.ON aqueous hydrochloric acid solution and extracted with toluene (3 ⁇ 25 ml).
  • the combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give the title compound as an oil, (0.746 g, 44.6%).
  • the toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4 ⁇ 25 ml).
  • the combined aqueous extracts were acidified to pH 2-3 with 5.ON aqueous hydrochloric acid solution and extracted with toluene (3 ⁇ 25 ml).
  • the combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give the title acid as a colorless oil, (0.816 g, 44%).
  • Rf. 0.24 (silica, hexane/ethyl acetate 2:1).
  • the toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4 ⁇ 25 ml).
  • the combined aqueous extracts were acidified to pH 2-3 with 5.ON aqueous hydrochloric acid solution and extracted with toluene (3 ⁇ 25 ml).
  • the combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give the title acid as a colorless oil which solidified on standing, (1.119 g, 62%).
  • Rf. 0.25 (silica, hexane/ethyl acetate 2:1).
  • a fifth charge of a 30% aqueous solution of hydrogen peroxide (0.11 ml) and a further quantity of sodium hydrogen carbonate (0.281 g, 33.5 mmol) was added, and the mixture stirred at 40° C. for 8 hours.
  • the mixture was partitioned between hexane (40 ml) and 5% aqueous sodium sulphite solution (25 ml) and the layers separated.
  • the hexane layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 5 ⁇ 40 ml).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The Invention provides a process for preparing a compound of the formula: ##STR1## or a base salt thereof, wherein R2 is hydrogen or C1 -C6 alkyl optionally substituted by up to 3 substituents each independently selected from the group consisting of C1 -C6 alkoxy and C1 -C6 alkoxy(C1 -C6 alkoxy)-; and R3 is C1 -C6 alkyl or benzyl, said benzyl group being optionally ring-substituted by up to 2 nitro or C1 -C4 alkoxy substituents comprising reacting a compound of the formula: ##STR2## wherein R1 is C1 -C4 alkyl, phenyl or benzyl or C1 -C4 alkoxy; and R2 and R3 are as previously defined for a compound of the formula (I), with hydrogen peroxide or a source of peroxide ions: said process being optionally followed by conversion of the compound of the formula (I) to a base salt thereof. The present invention also relates to novel compounds of the formula (II).

Description

FIELD OF THE INVENTION
This invention relates to a process for the preparation of glutaric acid derivatives.
BACKGROUND OF THE INVENTION
The invention relates to a process for the preparation of 1- 2-(alkoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid derivatives, the use of which has previously been disclosed in EP-A-0274334 as intermediates for the preparation of certain substituted glutaramide diuretic agents having utility in the treatment of hypertension, heart failure, renal insufficiency and in other disorders.
EP-A-0274234 describes two methods for the preparation of 1- 2-(alkoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid derivatives by which the dianion derived from cyclopentanecarboxylic acid by treatment with a strong base, e.g. lithium diisopropylamide, is treated with either (i) an acrylate derivative, or (ii) an ester of 3-bromopropanoic acid followed by optional further alkylation as required, to provide the desired products. However, the favored route, involving use of an acrylate derivative, can not be used for certain preferred embodiments of the present invention due to competing elimination reactions.
It has now been discovered that 1- 2-(alkoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid derivatives may be unexpectedly prepared by the oxidative rearrangement of 2-acyl- or 2-alkoxycarbonyl-cyclohexanone derivatives, offering further commercially important improvements over the existing processes such as ease and lower cost of operation.
SUMMARY OF THE INVENTION
The present invention provides a process for preparing a compound of the formula: ##STR3## or a base salt thereof, wherein R2 is hydrogen or C1 -C6 alkyl optionally substituted by up to 3 substituents each independently selected from C1 -C6 alkoxy and C1 -C6 alkoxy (C1 -C6 alkoxy)-; and R3 is C1 -C6 alkyl or benzyl, said benzyl group being optionally ring-substituted by up to 2 nitro or C1 -C4 alkoxy substituents, comprising reacting a compound of the formula: ##STR4## wherein R1 is C1 -C4 alkyl, phenyl, benzyl or C1 -C4 alkoxy; and R2 and R3 are as previously defined for a compound of the formula (I), with hydrogen peroxide or a source of peroxide ions. The process can followed by conversion of the compound of the formula (I) to a base salt thereof.
Preferably, R1 is C1 -C4 alkyl, phenyl or C1 -C4 alkoxy. More preferably, R1 is methyl, phenyl or ethoxy. Most preferably, R1 is methyl or ethoxy.
Preferably, R2 is hydrogen or C1 -C6 alkyl optionally substituted by one C1 -C6 alkoxy or C1 -C6 alkoxy (C1 -C6 alkoxy)- substituent.
More preferably, R2 is hydrogen, 2-methoxyethoxymethyl, 2-methoxyethyl or methoxymethyl.
Most preferably, R2 is hydrogen or 2-methoxyethoxymethyl.
Preferably, R3 is C1 -C6 alkyl or benzyl, said benzyl group being optionally ring-substituted by one nitro or C1 -C4 alkoxy substituent.
More preferably, R3 is ethyl, tert-butyl, benzyl, 4-nitrobenzyl or 4-methoxybenzyl.
Most preferably, R3 is tert-butyl.
Examples of base salts of the compounds of the formula (I) include alkali metal, alkaline earth metal, ammonium and mono-, di- or tri(C1 -C4 alkyl)ammonium salts.
Preferably the base salt of a compound of the formula (I) is the isopropylammonium salt.
The present invention also relates to novel compounds of the formula (II) which are useful as intermediates in the preparation of certain substituted glutaride diuretic agents having utility in the treatment of hypertension, heart failure, renal insufficiency, and in other disorders.
DETAILED DESCRIPTION OF THE INVENTION
The source of peroxide ions includes reagents such as hydrogen peroxide, peroxy acids (e.g. peroxy(C1 -C4)alkanoic acids), sodium perborate or a hydrate thereof, and sodium percarbonate, which are used in the presence of water. Preferably hydrogen peroxide, sodium perborate tetrahydrate or sodium percarbonate is used. Most preferably hydrogen peroxide is used.
The skilled man will appreciate that a certain amount of water must be present in the reaction mixture so that peroxide ions may be generated from the reagent.
The reaction is preferably carried out using hydrogen peroxide in the presence of water.
The reaction is preferably carried out in a suitable solvent in the presence of acid or base. Although the reaction does proceed slowly under neutral conditions, it has been found that acidic or basic reaction conditions accelerate the rate.
Suitable solvents for the reaction include C1 -C6 alkanols and toluene.
Preferably the solvent is methanol, tert-butanol or toluene.
Most preferably the solvent is tert-butanol.
When the reaction is carried out in the presence of acid, preferred acids include mineral acids and C1 -C4 alkanoic acids.
Preferably the acid is sulphuric acid or acetic acid. The reaction may also be carried out using a C1 -C4 alkanoic acid as the solvent in the absence of an additional acid. Acetic acid is preferred.
When the reaction is carried out in the presence of base, preferred bases include sodium or potassium hydroxide, carbonate or bicarbonate.
Preferably the base is sodium hydroxide or sodium or potassium bicarbonate.
Sodium percarbonate is a basic reagent per se and is typically not used in the presence of acid or a further base.
The reaction conditions and, in particular, the solvent and the nature and/or concentration of the acid or base used in the process provided by the present invention are chosen such that the reaction proceeds safely and at a favorable rate, without hydrolysis or transesterification of the ester functionality in the starting material (II) or product (I) occurring.
A preferred embodiment of the present invention provides a process for preparing a compound of the formula (I), or a base salt thereof, comprising reaction of a compound of the formula (II) with
(a) aqueous hydrogen peroxide in
(i) a suitable organic solvent in the presence of an acid,
(ii) a suitable organic solvent in the presence of a base, or
(iii) a C1 -C4 alkanoic acid;
(b) sodium perborate, or a hydrate thereof, in a C1 -C4 alkanoic acid; or
(c) sodium percarbonate in a suitable organic solvent in the presence of water: said process being optionally followed by a conversion of the compound of the formula (I) to a base salt thereof,
wherein R1, R2 and R3 are as previously defined for compounds of the formulae (I) and (II).
A most preferred embodiment of the present invention provides a process for preparing a compound of the formula (I), or a base salt thereof, comprising reaction of a compound of the formula (II) with
(a) aqueous hydrogen peroxide in
(i) tert-butanol or toluene in the presence of a catalytic amount of sulphuric acid,
(ii) either tert-butanol in the presence of sodium or potassium bicarbonate, or methanol in the presence of sodium hydroxide, or
(iii) acetic acid;
(b) sodium perborate tetrahydrate in acetic acid; or
(c) sodium percarbonate in tert-butanol in the presence of water: said process being optionally followed by conversion of the compound of the formula (I) to a base salt thereof, wherein R1, R2 and R3 are as previously defined for compounds of the formulae (I) and (II).
Sodium perborate is commercially available in several different hydrate forms, although the tetrahydrate (e.g. available from the Aldrich Chemical Company Ltd.) is preferred for the purpose of the present invention. Sodium perborate tetrahydrate may be formulated as either NaBO3.4H2 O or NaBO2.H2 O2.3H2 O and provides a source of peroxide ions in aqueous solution:
 B(OH).sub.3 (O.sub.2 H)!.sup.- +H.sub.2 O→ B(OH).sub.4 !.sup.- +H.sub.2 O.sub.2
(see F. A. Cotton and G. Wilkinson, Advanced Inorganic Chemistry, 5th Edition, page 172).
Sodium percarbonate is a commercially available (e.g. from Fluka Chemicals Ltd.) bleaching agent and provides a source of peroxide ions in the presence of water. The molecular formula is generally represented as Na2 CO3.3/2 H2 O2 (see Chem. Lett., 1986, 665-6).
Alkyl and alkoxy groups containing 3 or more carbon atoms and C4 -alkanoic acids may be straight or branched chain.
The process provided by the present invention may be carried out according to the following methods:
1. In a typical procedure, a stirred solution of a compound of the formula (II) in a suitable organic solvent, e.g. t-butanol or toluene, is cautiously treated with an aqueous (typically about 30 weight %) solution of hydrogen peroxide and a catalytic amount of a suitable acid, e.g. sulphuric acid, preferably maintaining the reaction temperature at below 50° C., most preferably at about room temperature, throughout the addition. The reaction is further stirred at room temperature for up to 24 hours although longer reaction times may be necessary. The product of the formula (I) is isolated and purified using conventional techniques.
2. In a typical procedure, a stirred solution of compound of the formula (II) in a suitable organic solvent, e.g. C1 -C4 alkanol such as tert-butanol or methanol, is cautiously treated with a suitable base, e.g. sodium or potassium hydroxide or bicarbonate, and an aqueous (typically about 30 weight %) solution of hydrogen peroxide, maintaining the reaction temperature at from 0° C. to 50° C. throughout the additions. The reaction is further stirred at from room temperature to 50° C. for up to 24 hours, or longer if necessary. The product of the formula (I) is isolated and purified by conventional techniques.
3. In a typical procedure, a stirred solution of a compound of the formula (II) in a C1 -C4 alkanoic acid, e.g. acetic acid, is cautiously treated with an aqueous (typically about 30 weight %) solution of hydrogen peroxide, maintaining the reaction temperature at below 40° C. throughout the addition to avoid hydrolysis of the ester functionalility. The reaction is further stirred at room temperature for up to 24 hours. The product of the formula (I) is isolated and purified using conventional techniques.
4. In a typical procedure, a stirred solution of a compound of the formula (II) in a C1 -C4 alkanoic acid, e.g. acetic acid, is treated portionwise with sodium perborate tetrahydrate maintaining the reaction temperature at below 20° C. during the addition. The mixture is further stirred at room temperature for up to 48 hours. The product of the formula (I) is isolated and purified using conventional techniques.
5. In a typical procedure, a stirred solution of a compound of the formula (II) in a suitable organic solvent, e.g. a C1 -C4 alkanol such as tert-butanol, is treated with sodium percarbonate at about room temperature. The reaction is stirred at from room temperature to 60° C. for about 24 hours. The product of the formula (I) is isolated and purified by conventional techniques.
It will be appreciated by the skilled man that the reaction time will vary in each individual case dependent on several factors, such as the nature of the substituents and the reaction temperature employed.
The course of the reaction may be monitored using conventional methods, e.g. thin-layer chromatography.
The starting materials of the formula (II) may be prepared by a Michael addition reaction as illustrated in Scheme 1, using comparable reaction conditions to those described by Kryshtal et al, Synthesis, 1979!, 107. ##STR5## wherein R1, R2 and R3 are as previously defined for a compound of the formula (I).
In a typical procedure, an acrylate derivative of the formula (IV) is added to a stirred mixture of a compound of the formula (III), potassium carbonate and a catalytic amount of benzyltriethylammonium chloride in toluene at about room temperature, and the reaction further stirred at from room temperature to 50° C., preferably at about 40° C., for up to 24 hours. The product of the formula (II) is isolated and purified using conventional techniques.
The reaction may also be performed in the absence of benzyltriethylammonium chloride by reacting a compound of the formula (III) with an acrylate derivative of the formula (IV) in the presence of a suitable base, e.g. potassium carbonate or potassium tert-botoxide, in a suitable organic solvent, e.g. a C1 -C4 tert-butanol) or acetonitrile, at about room temperature. When R2 is other than hydrogen in this reaction and potassium tert-butoxide is used as the base, it is preferably added to the reaction mixture at about -10° C. and this is followed by a period of stirring of the reaction at from 0° C. to room temperature. The product of the formula (II) is isolated and purified by conventional techniques.
The compounds of the formula (III) and the acrylate derivatives of the formula (IV) arc either known compounds which may also be commercially available, or are prepared by conventional methods in accordance with literature precedents.
A base salt of a compound of the formula (I) may be prepared by mixing together solutions containing approximately equimolar amounts of a compound of the formula (I) and a suitable base. The base salt is recovered by filtration or by filtration or by evaporation of the solvent.
The process provided by the invention is illustrated by the following Examples:
EXAMPLE I 2-(tert-Butoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid
To a solution of crude 2-acetyl-2- 2-(tert-butoxycarbonyl)-ethyl!cyclohexanone (see Preparations 1 and 2) (42 g, 0.15 mol) in t-butanol (84 ml) was cautiously added a 30% aqueous hydrogen peroxide solution (21 ml, 0.187 mol) and conc. sulphuric acid (0.25 ml, 98% w/w) at room temperature, maintaining the reaction temperature below 50° C. during the addition. The mixture was stirred at room temperature for 18 hours, partitioned between dichloromethane (100 ml) and water (100 ml), and the layers separated. The dichloromethane layer was washed with 5% aqueous sodium sulphite solution (50 ml), dried over magnesium sulphate, filtered and concentrated under reduced pressure to give a pale yellow solid. (43 g). The solid partially crystallized on standing overnight to provide, after collecting and washing with pentane, the title compound, (15.5 g).
The mother liquors were concentrated and purified by column chromatography on silica gel by eluting with ethyl acetate/hexane (1:10) to provide, after combination and evaporation of appropriate fractions, a further 14.47 g of the title compound (combined yield 29.97 g, 78%).
1 H-NMR (300 MHz, CDCl3): =1.45 (s, 9H), 1.45-1.60 (m, 2H), 1.62-1.78 (m, 4H), 1.92-1.99 (m, 2H), 2.11-2.21 (m, 2H), 2.21-2.33 (m, 2H) ppm.
EXAMPLE 2 1- 2-(tert-Butoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid
To a solution of 2-acetyl-2- 2-(tert-butoxycarbonyl)ethyl!-cyclohexanone (see Preparations 1 and 2) (2.0 g, 7.45 mmol) and concentrated sulphuric acid (98% w/w, one drop) in toluene (6.0 ml) was added, dropwise, a 30% aqueous solution of hydrogen peroxide (1.05 ml, 9.31 mmol) at room temperature. The mixture was stirred for 68 hours at room temperature, treated with a further quantity of a 30% aqueous solution of hydrogen peroxide (0.4 ml, 3.72 mmol) and stirred for a further 16 hours at room temperature. The mixture was partitioned between toluene (25 ml) and 5% aqueous sodium sulphite solution and the layers separated. The toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4×25 ml). The combined aqueous extracts were washed with toluene (25 ml), acidified to pH 2-3 with 5.0N aqueous hydrochloric acid solution and extracted with toluene (3×25 ml). The combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give an oil, (1.11 g, 61%). The crude product was crystallized from pentane (7.5 ml/g) to give the title compound as a colorless solid. Rf. 0.28 (silica, hexane/ethyl acetate 2:1).
1 H-NMR (300 MHz, CDCl3) =1.45 (s, 9H). 1.45-1.60 (m, 2H), 1.62-1.78 (m, 4H), 1.92-1.99 (m, 2H), 2.11-2.21 (m, 2H), 2.21-2.33 (m, 2H) ppm. Analysis %: Found: C, 64.26; H, 9.27; C13 H22 O4 requires C, 64.44; H, 9.15.
EXAMPLE 3 1- 2-Benzyloxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid
To a solution of crude 2-acetyl-2- 2-(benzyloxycarbonyl)-ethyl!cyclohexanone (see Preparation 3) (19.7 g, 0.065 mol) in tert-butanol (35 ml) at room temperature was cautiously added, over a period of 30 minutes, a 30% aqueous hydrogen peroxide solution (8.8 ml, 0.078 mol) and concentrated sulphuric acid (0.25 ml, 98% w/w). The mixture was stirred at room temperature for 20 hours, partitioned between dichloromethane (100 ml) and water (100 ml) and the layers separated. The dichloromethane layer was washed with a 5% aqueous sodium sulphite solution (50 ml), dried over magnesium sulphate, filtered and concentrated under reduced pressure. Purification of the residue by chromatography on silica gel by initially eluting with ethyl acetate/hexane (1:2 changing to 1:1), followed by neat ethyl acetate in the latter stages, gave, after combination and evaporation of appropriate fractions, the title compound as a yellow oil, (12.17 g, 72%). RF. 0.17 (silica, hexane/ethyl acetate/acetic acid, 74:25:1). IR (thin film): v=3800-2400, 1735, 1695, 1450 cm-1. Analysis %: Found: C, 69.70; H, 7.18; C16 H20 O4 requires: C, 69.55; H, 7.29.
EXAMPLE 4 1- 2-(Ethoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid
To a solution of 2-acetyl-2- 2-(ethoxycarbonyl)ethyl!-cyclohexanone (see Preparation 4) (40 g, 0.16 mol) in tert-butanol (85 ml) was added, dropwise, a 30% aqueous solution of hydrogen peroxide (21.7 ml, 0.19 mol) and concentrated sulfuric acid (0.25 ml, 98% w/w) at room temperature. The mixture was further stirred for 24 hours, partitioned between dichloromethane (100 ml) and distilled water (100 ml) and the layers separated. The dichloromethane layer was washed with 5% aqueous sodium sulphite solution, dried over magnesium sulphate, filtered and concentrated under reduced pressure to give a yellow oil, (34.35 g). Purification of this material by chromatography on silica by eluting with ethyl acetate/hexane (1:2 changing to 1:1), followed by neat ethyl acetate in the latter stages, gave, after combination and evaporation of appropriate fractions, the title compound as a yellow oil, (22.96 g, 67%). RF. 0.28 (silica, ethyl acetate/hexane, 1:1). 1 H-NMR (300 MHz, CDCl3): =1.31 (t, 3H), 1.47-1.62 (m, 2H), 1.62-1.82 (m, 4H), 1.92-2.08 (m, 2H), 2.10-2.27 (m, 2H), 2.32-2.46 (m, 2H), 4.19 (q, 2H) ppm. 13 C-NMR (75.5 MHz, CDCl3) 14.26, 25.15, 31.21, 33.56, 36.15, 53.21, 60.49, 173.38, 183.52 ppm.
EXAMPLE 5 1- 2-(tert-Butoxycarbonyl)-3-(2-methoxyethoxy)propyl!-1-cyclopentanecarboxylic acid
To a solution of 2-acetyl-2- 2-(tert-butoxycarbonyl)-3-(2-methoxyethoxy)propyl!cyclohexanone (see Preparations 5 and 11) (50 m9, 0.14 mmol) in tert-butanol (0.5 ml) was added a 30% aqueous hydrogen peroxide solution (0.02 ml, 0.168 mmol) and concentrated sulphuric acid (one drop) at room temperature. The mixture was stirred at room temperature for 4 hours, partitioned between dichloromethane (10 ml) and water (10 ml), and the layers separated. The aqueous layer was extracted with dichloromethane (2×10 ml), the combined organic extracts dried over magnesium sulphate, filtered and concentrated under reduced pressure to give the title compound, (49 mg). Rf. 0.36 (silica, ethyl acetate). 1 H-NMR (300 MHz, CDCl3) =1.43 (s, 9H), 1.43-1.60 (m, 2H), 1.61-1.65 (m, 4H), 1.78 (dd, 1H), 2.0 (dd, 1H), 2.08-2.20 (m, 2H), 2.59-2.70 (m, 1H), 3.38 (s, 3H), 3.48-3.65 (m, 6H) ppm.
EXAMPLE 6 1- 2-(tert-Butoxycarbonyl)-3-(2-methoxyethoxy)propyl!-1-cyclopentanecarboxylic acid isopropylamine salt (1:1)
To a solution of 2-acetyl-2- 2-tert-butoxycarbonyl)-3-(2-methoxyethoxy)propyl!cyclohexanone (see Preparations 5 and 11)) (5.45 g, 0.015 mol) in tert-butanol (10.9 ml) and concentrated sulphuric acid (one drop) was added a 30% aqueous hydrogen peroxide solution (2.1 ml, 0.018 mol) at room temperature. The mixture was stirred at room temperature for 24 hours, partitioned between dichloromethane (20 ml) and 2.0M aqueous sodium hydroxide solution (20 ml) and the layers separated. The dichloromethane layer was washed with water (10 ml), the combined aqueous extracts acidified to pH 2 with 5.0M aqueous hydrochloric acid solution and extracted with n-hexane (2×20 ml). The combined n-hexane extracts were washed with water (5 ml), concentrated under reduced pressure and azeotropically dried with ethyl acetate to give the title acid, (3.99 g, 96% by GC normalization). Rf. 0.44 (silica, ethyl acetate, 1% acetic acid). 13 C-NMR (75.5 MHz, CDCl3) =24.44, 24.80, 27.82, 34.97, 36.51, 37.29, 44.43, 53.35, 58.84, 70.06, 71.72, 73.20, 80.44, 173.88, 183.33 ppm.
The crude product (3.4 g, 0.01 mol) was dissolved in 34 ml of n-hexane and isopropylamine (0.61 g, 0.01 mol) added at room temperature. The precipitated salt was cooled to 0° C., granulated for 2 hours and collected to give the title compound (3.57 g, 72.1% overall yield; HPLC main band assay 98.7%), m.p. 84°-87° C. 1 H-NMR (300 MHz, CDCl3): =1.23 (d, 6H), 1.45 (s, 9H), 1.35-1.50 (m, 2H), 1.58-1.70 (m, 4H), 1.78 (dd, 1H), 1.88 (dd, 1H), 2.05-2.19 (m, 2H), 2.60-2.69 (m, 1H), 3.28 (heptet, 1H), 3.36 (s, 3H), 3.48-3.62 (m, 6H), 5.98 (brs, 3H) ppm. 13 C-NMR (75 MHz, CDCl3) =21.99, 24.51, 24.97, 27.86, 34.64, 37.14, 37.98, 43.05, 44.94, 54.57, 58.78, 69.91, 71.68, 73.48, 79.98, 174.79, 183.22 ppm. Analysis %: Found: C, 61.64; H, 10.30; N, 3.46; C20 H39 NO6 requires: C, 61.67; H, 10.09; N, 3.60.
EXAMPLE 7 1- 2-(4-Nitrobenzyloxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid
To a solution of 2-acetyl-2- 2-(4-nitrobenzyloxycarbonyl)-ethyl!cyclohexanone (see Preparation 8) (1.68 g, 4.85 mmol) in tert-butanol (3.3 ml) was added, dropwise, a 30% aqueous solution of hydrogen peroxide (0.65 ml, 5.82 mmol) and concentrated sulphuric acid (98% w/w, one drop) at room temperature. The mixture was stirred for 48 hours, partitioned between toluene (25 ml) and 5% aqueous sodium sulphite solution and the layers separated. The toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4×25 ml). The combined aqueous extracts were washed with toluene (25 ml), acidified to pH 2-3 with 5.ON aqueous hydrochloric acid solution and extracted with toluene (3×25 ml). The combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give an oil which solidified on standing, (0.96 g, 61.9%). The crude product was recrystallized from ethyl acetate/hexane 1:1 (3 ml/g) to give the title acid, m.p. 78°-80° C. Rf. 0.27 (silica, hexane/ethyl acetate 2:1+1% acetic acid). 1 H-NMR (300 MHz, CDCl3) 1.49-1.61 (m, 2H), 1.63-1.78 (m, 4H), 1.97-2.06 (m, 2H), 2.11-2.22 (m, 2H), 2.42-2.50 (m, 2H), 5.22 (s, 2H), 7.55 (d, 2H), 8.23 (d, 2H) ppm. 13 C-NMR (75 MHz, CDCl3): 24.98, 30.80, 33.12, 36.03, 52.86, 64.71, 123.68, 128.30, 143.03, 147.61, 172.71, 183.79 ppm. Analysis %: Found: C, 59.71; H, 5.86; N, 4.44; C16 H19 NO6 requires C, 59.81; H, 5.96; N, 4.36.
EXAMPLE 8 1- 2-(4-Methoxybenzyloxycarbonyl)ethyl!1-cyclopentanecarboxylic acid
To a solution of 2-benzoyl-2- 2-(4-methoxybenzyloxycarbonyl)-ethyl!cyclohexanone (see Preparation 9) (2.16 g, 5.47 mmol) in tert-butanol (4.3 ml) was added, dropwise, a 30% aqueous solution of hydrogen peroxide (0.74 ml, 6.56 mmol) and concentrated sulphuric acid (98% w/w, one drop) at room temperature. The mixture was stirred for 48 hours, partitioned between toluene (25 ml) and 5% aqueous sodium sulphite solution and the layers separated. The toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4×25 ml). The combined aqueous extracts were washed with toluene (25 ml), acidified to pH 2-3 with 5.ON aqueous hydrochloric acid solution and extracted with toluene (3×25 ml). The combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give the title compound as an oil, (0.746 g, 44.6%). RF. 0.16 silica, hexane/ethyl acetate 2:1). 1 H-NMR (300 MHz, CDCl3) =1.45-1.59 (m, 2H), 1.65-1.78 (m, 4H), 1.98-2.06 (m, 2H), 2.12-2.22 (m, 2H), 2.34-2.46 (m, 2H), 3.84 (s, 3H), 5.06 (s, 2H), 6.91 (d, 2H), 7.31 (d, 2H) ppm. Analysis %: Found: C, 67.05; H, 7.18; C17 H2205 requires C, 66.65; H, 7.24.
EXAMPLE 9 1- 2-(tert-Butoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid
To a solution of 2-acetyl-2- 2-(tert-butoxycarbonyl)ethyl!cyclohexanone (see Preparations 1 and 2) (2.06 g, 7.67 mmol) in methanol (8.0 ml) was added, dropwise, a 30% aqueous solution of hydrogen peroxide (1.04 ml, 9.21 mmol) at room temperature. The mixture was cooled to 0° C. and a 20% aqueous solution of sodium hydroxide (1.0 ml) added dropwise. The mixture was stirred for 24 hours at room temperature, partitioned between toluene (25 ml) and 5% aqueous sodium sulphite solution and the layers separated. The toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4×25 ml). The combined aqueous extracts were acidified to pH 2-3 with 5.ON aqueous hydrochloric acid solution and extracted with toluene (3×25 ml). The combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give the title acid as a colorless oil, (0.816 g, 44%). Rf. 0.24 (silica, hexane/ethyl acetate 2:1). 1 H-NMR (300 MHz, CDCl3) =1.45 (s, 9H), 1.45-1.60 (m, 2H), 1.62-1.78 (m,4H), 1.92-1.99 (m, 2H), 2.11-2.21 (m, 2H), 2.21-2.33 (m, 2H) ppm.
EXAMPLE 10 1- 2-(tert-Butoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid
To a solution of 2-acetyl-2- 2-(tert-butoxycarbonyl)ethyl!cyclohexanone (see Preparations 1 and 2) (2.0 g, 7.45 mmol) in tert-butanol (4.0 ml) was added, in one portion, sodium percarbonate (0.935 g, 5.96 mmol) at room temperature. The mixture was heated to 50°-55° C. for 8 hours, stirred at room temperature for 16 hours, partitioned between toluene (25 ml) and 5% aqueous sodium sulphite solution and the layers separated. The toluene layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 4×25 ml). The combined aqueous extracts were acidified to pH 2-3 with 5.ON aqueous hydrochloric acid solution and extracted with toluene (3×25 ml). The combined toluene extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure to give the title acid as a colorless oil which solidified on standing, (1.119 g, 62%). Rf. 0.25 (silica, hexane/ethyl acetate 2:1). 1 H-NMR (300 MHz, CDCl3): 1.45 (s, 9H), 1.45-1.60 (m, 2H), 162-1.78 (m, 4H), 1.92-1.99 (m, 2H), 2.11-2.21 (m, 2H), 2.21-2.33 (m, 2H) ppm.
EXAMPLE 11 1- 2-(tert-Butoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid
To a solution of 2-acetyl-2- 2-(tert-butoxycarbonyl)ethyl!cyclohexanone (see Preparations 1 and 2) (1.0 g, 3.72 mmol) in acetic acid (10 ml) was added sodium perborate tetrahydrate (0.57 g, 3.72 mmol) in one portion at 15° C. The mixture was mechanically stirred for 1 hour during which time the internal temperature rose to 18° C. A further portion of sodium perborate tetrahydrate (0.57 g, 3.72 mmol) was then added and the mixture stirred for a further 1 hour. After this time a final portion of sodium perborate tetrahydrate (0.57 g, 3.72 mmol) was added and the mixture stirred at room temperature for 48 hours. The reaction was filtered to remove solids and the filter pad washed with ethyl acetate (2×25 ml). The combined filtrate and washings were washed with 5% aqueous sodium sulphite solution (2×50 ml), dried over magnesium sulphate, filtered and concentrated under reduced pressure to give a colourless oil, (0.92 g). The crude product was crystallized from pentane (4 ml/g) to give the title acid as a colorless solid, (0.617 g, 68.5%). Rf. 0.3 (silica, hexane/ethyl acetate, 2:1). 1 H-NMR (300 MHz, CDCl3) 1.45 (s, 9H), 1.45-1.60 (m, 2H), 1.62-1.78 (m, 4H), 1.92-1.99 (m, 2H), 2.11-2.21 (m, 2H), 2.21-2.33 (m, 2H) ppm. Analysis %: Found: C, 64,32; H, 9.03; C13 H22 O4 requires: C, 64.44; H, 9.15.
EXAMPLE 12 1- 2-(tert-Butoxycarbonyl)ethyl!-1-cyclopentanecarboxylic acid
To a suspension of 2- 2-(tert-butoxycarbonyl)ethyl!-2-ethoxycarbonylcyclohexanone (see Preparation 10) (1.0 g, 3.35 mmol) and sodium hydrogen carbonate (0.281 g, 3.35 mmol) in tert-butanol (2.0 ml) was added, in four portions over a period of 1.5 hours, a 30% aqueous solution of hydrogen peroxide (4×0.11 ml, 4.0 mmol) at 40° C. The mixture was stirred at 40° C. for 20 hours. A fifth charge of a 30% aqueous solution of hydrogen peroxide (0.11 ml) and a further quantity of sodium hydrogen carbonate (0.281 g, 33.5 mmol) was added, and the mixture stirred at 40° C. for 8 hours. The mixture was partitioned between hexane (40 ml) and 5% aqueous sodium sulphite solution (25 ml) and the layers separated. The hexane layer was washed with dilute aqueous ammonia solution (25 ml of 0.880 ammonia in 200 ml of distilled water, 5×40 ml). The combined aqueous extracts were acidified to pH 2-3 with 5.ON aqueous hydrochloric acid solution and extracted with dichloromethane (3×25 ml). The combined dichloromethane extracts were washed with distilled water (25 ml), dried over magnesium sulphate, filtered and concentrated under reduced pressure to give the title compound as an oil, (0.362 g, 44.6%). Rf. 0.29 (silica, hexane/ethyl acetate 2:1). Analysis %: Found: C, 64.78; H, 9.39; C1 H22 O4 requires: C, 64.44; H, 9.15.
The following Preparations illustrates the preparation of certain intermediates used in the preceeding Examples:
PREPARATION 1 2-Acetyl-2- 2-(tert-butoxycarbonyl)ethyl!cyclohexanone
To a suspension of 2-acetylcyclohexanone (100 g, 0.71 mol), potassium carbonate (118.3 g, 0.85 mol) and benzyltriethylammonium chloride (3.18 g, 0.014 mol) in toluene (280 ml), was added, in one portion, tert-butyl acrylate (137.1 g, 155.2 ml, 1.07 mol) at room temperature. The suspension was stirred at 40° C. for 18 hours, diluted with distilled water (1 L) and toluene (500 ml), and the layers separated. The aqueous layer was extracted with toluene (3×500 ml), the combined toluene extracts dried over magnesium sulphate, filtered and concentrated under reduced pressure to give a brown oil, (197.8 g) Rf. 0.41 (silica, hexane/ethyl acetate, 3:1). The crude product was used without further purification.
An analytical sample was prepared from the crude reaction product by chromatography on silica gel by eluting with ethyl acetate/hexane (1:4) to provide, after combination and evaporation of appropriate fractions, the title compound as a colorless oil. IR (thin film): v=2980, 2940, 2870, 1725, 1695, 1500, 1365cm1. Analysis %: Found: C, 67.22; H, 8.64; C15 H24 O4 requires C, 67.14; H, 9.01.
PREPARATION 2 2-Acetyl-2- 2-(tert-butoxycarbonyl)ethyl!cyclohexanone
To a suspension of 2-acetylcyclohexanone (2.8 g, 0.02 mol) and potassium carbonate (2.8 g, 0.02 mol) in tert-butanol (16.8 ml) was added tert-butyl acrylate (3.33 g, 0.026 mol) over a period of 10 minutes at room temperature. The suspension was stirred at room temperature for 48 hours, diluted with distilled water (16.8 ml) and dichloromethane (16.8 ml) and the layers separated. The aqueous layer was extracted with dichloromethane (16.8 ml) and the combined dichloromethane extracts concentrated under reduced pressure to give a brown oil (5.05 g). The crude product was crystallized from n-pentane (50 ml) to give the title compound as a colorless solid, (3.02 g, 56.2%), m.p. 47°-53° C. Rf. 0.41 (silica, hexane/ethyl acetate 2:1). 1 H-NMR (300 MHz, CDCl3): =1.41-1.55 (m, 2H), 1.47 (s, 9H), 1.62-1.84 (m, 4H), 1.96-2.04 (m, 2H), 2.10-2.21 (m, 2H), 2.17 (s, 3H), 2.26-2.53 (m, 2H) ppm. Analysis %: Found: C, 66.89; H, 9.04; C15 H24 O4 requires C, 67.14; H, 9.01.
PREPARATION 3 2-Acetyl-2- 2-(benzyloxycarbonyl)ethyl!cyclohexanone
To a solution of 2-acetylcyclohexanone (9.6 g, 0.068 mol), potassium carbonate (11.3 g, 0.082 mol) and benzyltriethylammonium chloride (0.3 g, 0.0013 mol) in toluene (26 ml), was added benzyl acrylate (16.72 g, 0.103 mol) at room temperature. The mixture was heated at 40° C. for 20 hours, cooled, partitioned between water (200 ml) and toluene (200 ml) and toluene (200 ml) and the layers separated. The aqueous layer was extracted with toluene (2×200 ml), the combined organic extracts dried over magnesium sulphate, filtered and concentrated under reduced pressure to provide the title compound as a pale yellow oil, (20.7 g), Rf. 0.2 (silica, hexane/diethyl ether, 2:1). The crude product was used without further purification.
An analytical sample was prepared from the crude reaction product by chromatography on silica gel by eluting with hexane/ether (2:1) to provide, after combination and evaporation of appropriate fractions, the product as a colorless oil. IR (thin film): v =2940, 2870, 1735, 1715, 1695, 1450cm-1. Analysis %: Found: C, 71.57; H, 7.45; C18 H22 O4 requires: C, 71.50; H, 7.33%.
PREPARATION 4 2-Acetyl-2- 2-(ethoxycarbonyl)ethyl!cyclohexanone
To a solution of 2-acetylcyclohexanone (25 g, 0.18 mol), potassium carbonate (29.5 g, 0.21 mol) and benzyltriethylammonium chloride (0.8 g, 0.0035 mol) in toluene (70 ml) was added ethyl acrylate (29 ml, 27 g, 0.27 mol) at room temperature. The mixture was heated at 40° C. for 20 hours, filtered and partitioned between distilled water (200 ml) and toluene (200 ml). The organic layer was dried over magnesium sulphate, filtered and concentrated under reduced pressure to give the title compound as a brown oil, (41.7 g, 97%).
The crude product was used in Example 4 without further purification.
PREPARATION 5 2-Acetyl-2- 2-tert-butoxycarbonyl)-3-(2-methoxyethoxy)propyl!cyclohexanone
To a suspension of 2-acetylcyclohexanone (103 mg, 0.88 mmol), potassium carbonate (121 mg, 0.88 mmol) and benzyltriethylammonium chloride (3 mg, 0.015 mmol) in toluene (0.5 ml) was added, in one portion, tert-butyl 2-(2-methoxyethoxymethyl)acrylate (see Preparations 6 and 7) (191 mg, 0.88 mmol) at room temperature. The suspension was stirred at room temperature for 18 hours, at 40° C. for 8 hours, cooled and diluted with water (10 ml) and extracted with ethyl acetate (3×10 ml). The combined organic extracts were dried over magnesium sulphate and concentrated to dryness under reduced pressure. The crude product was purified by flash column chromatography on silica gel by eluting with hexane/ethyl acetate (2:1) to provide, after combination and evaporation of appropriate fractions, the desired product as a colorless oil, (86 mg). Rf. 0.2 (silica, hexane/ethyl acetate, 2:1). IR (thin film: v=2980, 2935, 2870, 1720, 1695, 1450cm-1. Analysis %: Found: C, 64.22; H, 9.03; C19 H32 O6 requires: C, 64.02; H, 9.03.
PREPARATION 6 tert-Butyl 2-(2-methoxyethoxymethyl)acrylate
To a solution of tert-butyl 2-(bromomethyl)acrylate (2.0 g, 9.0 mmol) in 2-methoxyethanol (30 ml) at 0° C. was added, in one portion, potassium carbonate (2.5 g, 18 mmol) and the mixture stirred at 0° C. for 1 hour. The reaction was diluted with distilled water (100 ml) and extracted with dichloromethane (100 ml). The layers were separated and the aqueous layer further extracted with dichloromethane (2×50 ml). The combined organic extracts were dried over magnesium sulphate, filtered and concentrated under reduced pressure. The residue was purified by chromatography on silica by eluting with hexane/ethyl acetate (2:1) to give, after combination and evaporation of appropriate fractions, the title compound as a yellow oil, (1.6 g, 82%). Rf. 0.32 (silica, hexane/ethyl acetate, 2:1). 1 H-NMR (300 MHz, CDCl3) 1.50 (s, 9H), 3.42 (s, 3H) , 3.56-3.63 (m, 2H), 3.65-3.74 (m, 2H), 4.25 (s, 2H), 5.84 (s, 1 H), 6.25 (s, 1H) ppm.
PREPARATION 7 tert-Butyl 2-(2-methoxyethoxymethyl)acrylate a. tert-Butyl 2-(4methylphenylsulphonylmethyl) acrylate
To a solution of tert-butyl methacrylate (10 g, 70.3 mmol) in dichloromethane (44 ml) was added, in one portion, p-toluenesulphinic acid, sodium salt, dihydrate (15 g, 70.3 mmol) followed by iodine (17.8 g, 70.3 mmol) and the mixture stirred at room temperature for 24 hours. The reaction was cooled to 0° C. and triethylamine (10.6 g, 105.4 mmol) was added over a period of 10 minutes. The mixture was stirred at 0° C. for 15 minutes and at room temperature for 3 hours, diluted with dichloromethane (100 ml) and distilled water (100 ml). The layers were separated and the aqueous layer further extracted with dichloromethane (50 ml). The combined organic extracts were washed with 1.ON aqueous hydrochloric acid solution (50 ml), saturated aqueous sodium hydrogen carbonate solution (50 ml), distilled water (50 ml) and concentrated under reduced pressure to give a yellow-brown oil, (19.63 g). The material was dissolved in ethyl acetate (40 ml) and triethylamine (7.1 g, 70.3 mmol) added. The mixture was heated at reflux for 8 hours and stirred at room temperature for 16 hours, washed with distilled water (100 ml), 1.ON aqueous hydrochloric acid solution (100 ml), saturated aqueous sodium hydrogen carbonate solution (100 ml) and the organic layer concentrated under reduced pressure to give a yellow-brown oil (17 g). The crude product was crystallized from hexane/ethyl acetate 4:1 (5 ml/g) to give the title compound as a yellow solid, (13.09 g, 62.8%; 98.64% pure by GC normalization). Rf. 0.31 (silica, hexane/ethyl acetate, 3:1). 1 H-NMR (300 MHz, CDCl3) =1.35 (s, 9H), 2.48 (s, 3H), 4.12 (s, 2H), 5.91 (s, 1H), 6.47 (s, 1H), 7.34 (d, 2H), 7.75 (d, 2H) ppm. 13 C-NMR (75 MHz, CDCl3): 21.67, 27.81, 57.54, 81.73, 128.91, 129.70, 130.55, 132.53, 135.63, 144.83, 163.80 ppm. Analysis %: Found: C, 60.76; H, 6.80; C15 H20 O4 S requires: C, 60.79; H, 6.80.
b. tert-Butyl 2-(2-methoxyethoxymethyl)acrylate
To a suspension of the product of part (a) (14 g, 0.047 mmol) in 2-methoxyethanol (70 ml) at )°C. was added, in one portion, potassium carbonate (13.06 g, 0.094 mol) and the mixture stirred at 0° C. for 3 hours. The reaction was diluted with distilled water (100 ml) and extracted with dichloromethane (100 ml). The layers were separated and the aqueous layer further extracted with dichloromethane (50 ml) and the combined organic extracts concentrated under reduced pressure. The residue was purified by chromatography on silica eluting with hexane/ethyl acetate (6:1) to give, after combination and evaporation of appropriate fractions, the title compound as a colorless oil, (8.62 g, 84%). Rf. 0.32 (silica, hexane/ethyl acetate, 2:1. 1 H-NMR (300 MHz, CDCl3): 1.50 (s, 9H), 3.42 (s, 3H), 3.56-3.63 (m, 2H), 3.65-3.74 (m, 2H), 4.25 (s, 2H), 5.84 (s, 1H), 6.25 (s, 1H) ppm.
PREPARATION 8 2-Acetyl-2- 2-(4-nitrobenzyloxycarbonyl)ethyl!cyclohexanone
The title compound was prepared in 69% yield after chromatography (silica gel, gradient elution with hexane/ethyl acetate) from 2-acetylcyclohexanone and p-nitrobenzyl acrylate using a similar method to that used in Preparation 2. Rf. 0.2 (silica, hexane/ethyl acetate, 2:1). 1 H-NMR (300 MHz, CDCl3) 1.40-1.78 (m, 4H), 1.89-2.47 (m, 8H), 2.07 (s, 3H), 5.13 (s, 2H), 7.45 (d, 2H), 8.17 (d, 2H) ppm. Analysis %: Found: C, 62.75; H, 5.90; N, 3.87; C18 H21 NO6 requires C, 62.24; H, 6.09; N, 4.03.
PREPARATION 9 2-Benzoyl-2- 2-(4-methoxybenzyloxycarbonyl)ethyl!cyclohexanone
The title compound was prepared in 65.5% yield after chromatography (silica gel, hexane/ethyl acetate 4:1) from 2-benzoylcyclohexanone and p-methoxybenzyl acrylate using a similar method to that used in Preparation 2. (M+ 394.13, 53%). Rf 0.39 (silica, hexane/ethyl acetate (2:1). 1 H-NMR (300 MHz, CDCl3): =1.38-1.49 (m, 1 H), 1.68-1.82 (m, 3H), 1.98-2.57 (m, 7H), 2.82-2.91 (m, 1H), 3.82 (s, 3H), 5.03 (s, 2H), 6.87 (d, 2H), 7.26 (d, 2H), 7.42 (t, 2H), 7.56 (t, 1H), 7.88 (d, 2H) ppm. Analysis %: Found: C, 73.05; H, 6.74; C24 H26 O5 requires C, 73.08; H, 6.64.
PREPARATION 10 2- 2-(tert-Butoxycarbonyl)ethyl!-2-ethoxycarbonylcyclohexanone
To a solution of 2-ethoxycarbonylcyclohexanone (5.0 g, 0.029 mol) and tert-butyl acrylate (4.83 g, 0.037 mol) in tert-butanol (30 ml) was added, in one portion, potassium carbonate (4.0 g, 0.029 mol). The suspension was stirred at room temperature for 22 hours, diluted with dichloromethane (100 ml) and distilled water (100 ml) and the layers separated. The aqueous layer was extracted with dichloromethane (2×100 ml) and the combined dichloromethane extracts dried over magnesium sulphate, filtered and concentrated under reduced pressure. The residue was purified by chromatography on silica by eluting with hexane/ethyl acetate (4:1) to give, after combination and evaporation of appropriate fractions, the title compound as a colorless oil, (7.99 g, 92.3%; 98.92% by GC normalization) MH+ 299.03, 8.53%). Rf. 0.15 (silica, hexane/ethyl acetate 4:1). 1 H-NMR (300 MHz, CDCl3) =1.20 (t, 3H), 1.37 (s, 9H), 1.52-2.46 (m, 12H), 4.08-4.21 (m, 2H) ppm. 13 C-NMR (62 MHz, CDCl3) =13.97, 22.38, 27.36, 27.91, 29.52, 30.49, 36.06, 40.85, 59.87, 61.19, 80.10, 171.61, 172.22, 207.39 ppm. Analysis %: Found: C, 64.19; H, 8.80; C16 H26 O5 requires C, 64.41; H, 8.78.
PREPARATION 11 2-Acetyl-2- 2-(tert-butoxycarbonyl)-3-(2-methoxyethoxy)propyl!cyclohexanone
To a suspension of 2-acetylcyclohexanone (3.5 g, 0.025 mol) and tert-butyl 2-(2-methoxyethoxymethyl)acrylate (see Preparations 6 and 7) (5.41 g, 0.025 mol) in acetonitrile (20 ml) was added, in one portion, potassium tert-butoxide (0.14 g, 0.0012 mol) at -10° C. The mixture was stirred at -10° C. for 24 hours, at 0° C. for 6 hours and at room temperature for 18 hours. The mixture was partitioned between ethyl acetate (15 ml) and distilled water (30 ml) and the layers separated. The aqueous layer was extracted with eithyl acetate (2×15 ml) and the combined ethyl acetate extracts concentrated under reduced pressure to give a brown oil (7.52 g). The residue was purified by chromatography on silica by eluting with hexane/ethyl acetate (4:1) to give, after combination and evaporation of appropriate fractions, the title compound as a colorless oil, (4.98 g, 55.8%). Rf. 0.23 (silica, hexane/ethyl acetate, 2:1). Analysis %: Found: C, 64.44; H, 9.02; C19 H32 O6 requires: C, 64.02; H, 9.05.

Claims (16)

I claim:
1. A process for preparing a compound of the formula: ##STR6## or a base salt thereof, wherein R2 is hydrogen or C1 -C6 alkyl optionally substituted by up to 3 substituents each independently selected from the group consisting of C1 -C6 alkoxy and C1 -C6 alkoxy (C1 -C6 alkoxy)-; and R3 is C1 -C6 alkyl or benzyl, said benzyl group being optionally ring-substituted by up to 2 nitro or C1 -C4 alkoxy substituents,
comprising: reacting a compound of the formula: ##STR7## wherein R1 is C1 -C4 alkyl, phenyl, benzyl or C1 -C4 alkoxy; and R2 and R3 are as previously defined for a compound of the formula (I), with peroxide ions.
2. The process of claim 1, further including conversion of the compound of formula (I) to a base salt thereof.
3. The process of claim 1 in which the source of the peroxide ions is hydrogen peroxide, a peroxy(C1 -C4) alkanoic acid, sodium perborate or a hydrate thereof, or sodium percarbonate, and in which water is present in said reacting step.
4. The process of claim 1 in which the source of the peroxide ions is hydrogen peroxide and in which water is present in said reacting step.
5. The process of claim 1 wherein said reacting step is carried out in a suitable solvent and in the presence of an acid.
6. The process of claim 1 wherein said reacting step is carried out in a suitable solvent and in the presence of a base.
7. The process of claim 5 wherein the solvent is tert-butanol.
8. The process of claim 5 wherein the acid is a mineral acid.
9. The process of claim 8 wherein the mineral acid is sulphuric acid.
10. The process of claim 1 wherein said reacting step is carried out in acetic acid.
11. The process of claim 6 wherein the base is selected from the group consisting of sodium hydroxide, sodium carbonate, sodium bicarbonate, potassium hydroxide, potassium carbonate, and potassium bicarbonate.
12. The process of claim 11 wherein the base is selected from the group consisting of sodium bicarbonate and potassium bicarbonate.
13. The process of claim 1 wherein R1 is C1 -C4 alkyl, phenyl or C1 -C4 alkoxy; R2 is hydrogen or C1 -C6 alkyl optionally substituted by one C1 -C6 alkoxy or C1 -C6 alkoxy (C1 -C6 alkoxy)- substituent; and R3 is C1 -C6 alkyl or benzyl, said benzyl group being optionally ring-substituted by one nitro or C1 -C4 alkoxy substituted.
14. The of claim 13 wherein R1 is methyl, phenyl or oxy; R2 is hydrogen, 2-methoxyethoxymethyl, 2-methoxyethyl or methoxymethyl; and R3 is ethyl, tert-butyl, benzyl, 4-nitrobenzyl or 4-methoxybenzyl.
15. The process of claim 13 wherein R1 is methyl or ethoxy; R2 is hydrogen or 2-methoxyethoxymethyl; and R3 is tert-butyl.
16. A process for preparing a compound of the formula: ##STR8## wherein R2 is hydrogen or C1 -C6 alkyl optionally substituted by up to 3 substituents each independently selected from the group consisting of C1 -C6 alkoxy and C1 -C6 alkoxy(C1 -C6 alkoxy)-; and R3 is C1 -C6 alkyl or benzyl, said benzyl group being optionally ring-substituted by up to 2 nitro or C1 -C4 alkoxy substituents, comprising: reacting a compound of the formula: ##STR9## wherein R1 is C1 -C4 alkyl, phenyl or benzyl; and R2 and R3 are as defined for the formula (I), with a source of peroxide ions under acidic conditions.
US08/856,612 1989-04-05 1997-05-15 Preparation of glutaric acid derivatives Expired - Lifetime USRE35865E (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US08/856,612 USRE35865E (en) 1989-04-05 1997-05-15 Preparation of glutaric acid derivatives

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898907704A GB8907704D0 (en) 1989-04-05 1989-04-05 Preparation of glutaric acid derivatives
GB8907704 1989-04-05
US07/504,493 US5166406A (en) 1989-04-05 1990-04-04 Preparation of glutaric acid derivatives
US08/856,612 USRE35865E (en) 1989-04-05 1997-05-15 Preparation of glutaric acid derivatives

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US07/504,493 Reissue US5166406A (en) 1989-04-05 1990-04-04 Preparation of glutaric acid derivatives

Publications (1)

Publication Number Publication Date
USRE35865E true USRE35865E (en) 1998-07-28

Family

ID=10654523

Family Applications (2)

Application Number Title Priority Date Filing Date
US07/504,493 Ceased US5166406A (en) 1989-04-05 1990-04-04 Preparation of glutaric acid derivatives
US08/856,612 Expired - Lifetime USRE35865E (en) 1989-04-05 1997-05-15 Preparation of glutaric acid derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US07/504,493 Ceased US5166406A (en) 1989-04-05 1990-04-04 Preparation of glutaric acid derivatives

Country Status (28)

Country Link
US (2) US5166406A (en)
EP (1) EP0391673B2 (en)
JP (1) JPH0761978B2 (en)
KR (1) KR920005848B1 (en)
CN (1) CN1028023C (en)
AT (1) ATE90331T1 (en)
CA (1) CA2013743C (en)
DD (1) DD293343A5 (en)
DE (1) DE69001852T3 (en)
DK (1) DK0391673T3 (en)
EG (1) EG19016A (en)
ES (1) ES2055321T5 (en)
FI (1) FI93722C (en)
GB (1) GB8907704D0 (en)
GR (1) GR3023288T3 (en)
HU (1) HU206189B (en)
IE (1) IE62931B1 (en)
IL (1) IL93945A (en)
MX (1) MX173989B (en)
MY (1) MY105529A (en)
NO (1) NO173233C (en)
NZ (1) NZ233196A (en)
PH (1) PH27240A (en)
PL (1) PL163316B1 (en)
PT (1) PT93644B (en)
RU (1) RU1838292C (en)
YU (1) YU65890A (en)
ZA (1) ZA902590B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714628A (en) * 1989-04-05 1998-02-03 Pfizer, Inc. Preparation of glutaric acid derivatives
US7040559B2 (en) 2004-04-02 2006-05-09 Fellowes Inc. Shredder with lock for on/off switch
US7631822B2 (en) * 2004-09-10 2009-12-15 Fellowes Inc. Shredder with thickness detector
KR102846783B1 (en) * 2021-08-02 2025-08-19 주식회사 미토이뮨테라퓨틱스 Novel Indole derivatives, Pharmaceutical composition comprising the same, and Use thereof
CN120157578B (en) * 2025-03-17 2025-11-18 质肽药业(泰州)有限公司 Preparation method of mono-tert-butyl octadecanedioate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274234A2 (en) * 1986-12-11 1988-07-13 Pfizer Limited Spiro-subsituted glutaramide diuretic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2466926A (en) 1947-06-26 1949-04-12 Rohm & Haas 2-acyl-2-(beta-carbalkoxyethyl)-cycloalkanones
US2466678A (en) 1947-06-26 1949-04-12 Rohm & Haas Acylated suberates and azelates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274234A2 (en) * 1986-12-11 1988-07-13 Pfizer Limited Spiro-subsituted glutaramide diuretic agents

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Allinger, "Organic Chemistry," p. 524, 1974.
Allinger, Organic Chemistry, p. 524, 1974. *
Mannich, Ber., 74, 1007 (1941). *
Middeton, Aust. J. Chem., vol. 33, pp. 2467 2476, 1980. *
Middeton, Aust. J. Chem., vol. 33, pp. 2467-2476, 1980.
Payne, J. Org. Chem., vol. 24, pp. 4793 4797, 1961. *
Payne, J. Org. Chem., vol. 24, pp. 4793-4797, 1961.
Zavialov, Tetrahedron, vol. 20, pp. 2745 2750, 1964. *
Zavialov, Tetrahedron, vol. 20, pp. 2745-2750, 1964.

Also Published As

Publication number Publication date
FI901699A0 (en) 1990-04-04
ATE90331T1 (en) 1993-06-15
JPH0761978B2 (en) 1995-07-05
DE69001852T2 (en) 1993-09-16
RU1838292C (en) 1993-08-30
MY105529A (en) 1994-10-31
FI93722C (en) 1995-05-26
JPH02290830A (en) 1990-11-30
DE69001852D1 (en) 1993-07-15
DD293343A5 (en) 1991-08-29
CA2013743C (en) 1998-05-12
KR900016086A (en) 1990-11-12
AU5291290A (en) 1990-11-01
YU65890A (en) 1991-10-31
PL163316B1 (en) 1994-03-31
NO173233C (en) 1993-11-17
CA2013743A1 (en) 1990-10-05
ES2055321T5 (en) 1997-06-16
DK0391673T3 (en) 1993-06-28
IE62931B1 (en) 1995-03-08
PT93644A (en) 1990-11-20
AU609700B2 (en) 1991-05-02
IL93945A (en) 1994-12-29
HUT53586A (en) 1990-11-28
MX20151A (en) 1993-09-01
GR3023288T3 (en) 1997-07-30
DE69001852T3 (en) 1997-06-05
FI93722B (en) 1995-02-15
EP0391673B2 (en) 1997-04-02
MX173989B (en) 1994-04-13
HU902079D0 (en) 1990-08-28
US5166406A (en) 1992-11-24
KR920005848B1 (en) 1992-07-23
GB8907704D0 (en) 1989-05-17
EP0391673A1 (en) 1990-10-10
CN1028023C (en) 1995-03-29
ZA902590B (en) 1991-11-27
EP0391673B1 (en) 1993-06-09
IL93945A0 (en) 1990-12-23
PH27240A (en) 1993-05-04
NO173233B (en) 1993-08-09
NO901534D0 (en) 1990-04-04
EG19016A (en) 1994-07-30
NZ233196A (en) 1991-09-25
HU206189B (en) 1992-09-28
ES2055321T3 (en) 1994-08-16
NO901534L (en) 1990-10-08
CN1046153A (en) 1990-10-17
PT93644B (en) 1998-06-30
IE901213L (en) 1990-10-05

Similar Documents

Publication Publication Date Title
EP2181986B1 (en) Process for the preparation of a precursor of montelukast
US4074057A (en) 2-Halopropionic acid and its derivatives
USRE35865E (en) Preparation of glutaric acid derivatives
EP0169688B1 (en) Process for preparing anti-inflammatory cycloalkylidenemethylphenylacetic acid derivatives
US3953490A (en) Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile
US5714628A (en) Preparation of glutaric acid derivatives
Yang et al. Di-p-nitrobenzyl azodicarboxylate (DNAD): an alternative azo-reagent for the Mitsunobu reaction
US4645839A (en) Sulphur dehydrogenation process to yield 5-methyl-2-pyridone
US4692545A (en) Method for preparation of mercaptobenzoates
US4499294A (en) Process for production of methyl 2-tetradecylgycidate
US4020129A (en) Production of dithiophosphoric acid-O,O-diesters
US2889325A (en) Derivatives of 1, 3 (2h)-dioxo-1-pyrazolo [a]-benzo [c] cinnoline
EP0150026A2 (en) Chemical process
US4358606A (en) Esters of phenalkyloxycarbonylamino acids
EP0101570B1 (en) Method for the resolution of racemic 2-cp-difluoromethoxy phenyl)-3-methylbutyric acid
US4304942A (en) Producing substituted 2-cyclopentenones
GB2159156A (en) Process for the preparation of alkyl 3-chlorosulfonylthiophene-2-carboxylate
US5091068A (en) Preparation of 3-trichloromethyl-pyridine
US4540524A (en) Methods for preparing lower alkyl α-fluoro-α-cyanoacetate and its carbanion
EP0065706B1 (en) Process for the preparation of 3,3-dimethylglutaric acid or its esters
US4034050A (en) Preparation of 5-methyl-2-nitrophenol
DE2539547A1 (en) PGF DEEP BETA -PROSTAGLANDINE, METHOD OF MANUFACTURING IT AND THERAPEUTIC USE
CS231862B1 (en) Manufacturing process of alkyl 2-<substituted fenoxy>alcanoate
JPS5933280A (en) 2-methoxy-4,6-dipyridinium-1,3,5-triazine dihalide, its preparation and condensing agent containing the same as active constituent
CH491853A (en) Process for preparing the ethyl ester of a derivative of fluoracetic acid

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FEPP Fee payment procedure

Free format text: PETITION RELATED TO MAINTENANCE FEES FILED (ORIGINAL EVENT CODE: PMFP); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FEPP Fee payment procedure

Free format text: PETITION RELATED TO MAINTENANCE FEES GRANTED (ORIGINAL EVENT CODE: PMFG); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 8

SULP Surcharge for late payment
FPAY Fee payment

Year of fee payment: 12

SULP Surcharge for late payment

Year of fee payment: 11